Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO
September 18, 2024 07:00 ET
|
OXB
Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 September 2024: OXB (LSE:OXB), a quality and innovation-led cell and gene...